Micah Jacobs, MD
Infectious Disease · Pittsburgh, PANPI 1386845022
Payments from drug & device makers
Across 668 payments — averaging $354.07 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$139K
- Cumberland Pharmaceuticals, Inc.$44K
- Merck$31K
- Paratek Pharmaceuticals, Inc.$6K
- Ferring Pharmaceuticals AS$6K
- Insmed, Inc.$5K
- plus $5K from 16 others
What the payments were for
- Consulting fees$9,2995%
- Speaking & faculty fees$167,32781%
- Travel & lodging$17,0038%
- Food & beverage$11,4886%
- Education$5240%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 327 | $139,063 |
| Cumberland Pharmaceuticals, Inc. | 114 | $44,323 |
| Merck | 61 | $31,086 |
| Paratek Pharmaceuticals, Inc. | 38 | $6,017 |
| Ferring Pharmaceuticals AS | 4 | $5,650 |
| Insmed, Inc. | 45 | $5,258 |
| Invivyd Inc | 12 | $2,693 |
| Astellas Pharma US Inc | 18 | $632 |
| BD | 1 | $542 |
| Melinta Therapeutics, LLC | 20 | $532 |
| Aimmune Therapeutics, Inc. | 9 | $169 |
| Shionogi Inc | 3 | $163 |
| Tetraphase Pharmaceuticals, Inc. | 4 | $88 |
| Ferring Pharmaceuticals Inc. | 1 | $88 |
| Johnson & Johnson | 2 | $49 |
| Gilead | 2 | $46 |
| La Jolla Pharmaceutical Company | 2 | $43 |
| Nestle Healthcare Nutrition Inc. | 1 | $16 |
| Mayne Pharma Commercial LLC | 1 | $16 |
| Mylan Specialty L.p. | 1 | $15 |
| Nabriva Therapeutics, PLC | 1 | $14 |
| Tactile Systems Technology Inc | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$236,515 in reported general payments places this provider in the 90th percentile of 457 infectious disease providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ampicillin-SulbactamAmpicillin Sod/Sulbactam Sod | 14 | $2,708 |
| CeftriaxoneCeftriaxone Sodium | 36 | $2,356 |
| Cephalexin | 81 | $1,636 |
| Clarithromycin | 25 | $1,325 |
| Doxycycline Hyclate | 58 | $1,287 |
| Ethambutol Hcl | 21 | $1,282 |
| Cefazolin Sodium | 17 | $935 |
| Rifampin | 28 | $901 |
| Azithromycin | 18 | $306 |
| Fluconazole | 14 | $285 |
| Doxycycline Monohydrate | 12 | $238 |
| Ciprofloxacin Hcl | 18 | $170 |
| Amoxicillin | 40 | $168 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 32 | $130 |
Paid to pharmacies, not to this prescriber.
Other infectious disease in Pittsburgh
- Ghady HaidarPittsburgh$3.7M
- Sharon RiddlerPittsburgh$1.6M
- Chiu Bin HsiaoPittsburgh$1.6M
- Fernanda SilveiraPittsburgh$1.4M
- Minh-Hong NguyenPittsburgh$1.4M
- Amesh AdaljaPittsburgh$415K
- Booth WainscoatPittsburgh$139K
- Brandon SmithPittsburgh$108K
- Yohei DoiPittsburgh$78K
- Lee HarrisonPittsburgh$70K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.